CynergisTek (CTEK) Stock Price, News & Analysis

Company Overview

CynergisTek, Inc. provides cyber security, privacy, and compliance services in the United States. The company identifies, measures, and tests security and privacy risk of organization, as well as verifies and validates their programs to meet compliance and business objectives through IT audits, technical testing, and risk and program assessments; develops policies, procedures, and playbooks to help build out a risk management program; and verifies the processes, people, and technology are working effectively. It also provides insights to the ROI of an organization's security investment; resources to help organizations prioritize, implement, and execute initiatives to strengthen their security and privacy programs; and on-going management and oversight organization's security and privacy programs to address or give alerts when an issue arises. It serves primarily in the healthcare industry, as well as education, financial services, government, internet and media, and manufacturing industries under the CynergisTek, Redspin, and Backbone Consulting brands. The company was formerly known as Auxilio, Inc. and changed its name to CynergisTek, Inc. in September 2017. CynergisTek, Inc. was incorporated in 1995 and is based in Austin, Texas.

Key Stats

• Today's Range: $1.23 to $1.25
• 50-Day Range: N/A
• 52-Week Range: $0.58 to $2.04
• Volume: 167,600 shs
• Average Volume: 293,474 shs
• Market Capitalization: $16.57 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CTEK Stock Analysis - Frequently Asked Questions

How have CTEK shares performed this year?

CynergisTek's stock was trading at $1.25 at the beginning of 2025. Since then, CTEK shares have increased by 0.0% and is now trading at $1.25.
View the best growth stocks for 2025 here.

How were CynergisTek's earnings last quarter?

CynergisTek, Inc. (NYSEAMERICAN:CTEK) announced its earnings results on Thursday, November, 11th. The company reported $0.10 EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.22. The firm had revenue of $3.83 million for the quarter. CynergisTek had a negative net margin of 61.80% and a negative trailing twelve-month return on equity of 42.78%.

How do I buy shares of CynergisTek?

Shares of CTEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of CynergisTek own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CynergisTek investors own include Corbus Pharmaceuticals (CRBP), BIOLASE (BIOL), Carnival Co. & (CCL), Peabody Energy (BTU), Dynavax Technologies (DVAX), General Electric (GE) and Kinross Gold (KGC).

Company Calendar

• Last Earnings: 11/11/2021
• Today: 4/02/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Business Services
• Industry: Business Services
• Sub-Industry: N/A
• Current Symbol: NYSEAMERICAN:CTEK
• Previous Symbol: NYSEMKT:CTEK
• CIK: 1011432
• Web: www.cynergistek.com
• Phone: (512) 402-8550
• Fax: 949-614-0701
• Employees: 89
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.17)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-2,250,000.00
• Net Margins: -61.80%
• Pretax Margin: -30.59%
• Return on Equity: -42.78%
• Return on Assets: -36.36%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.69
• Quick Ratio: 1.69

Sales & Book Value

• Annual Sales: $16.30 million
• Price / Sales: 1.02
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.15 per share
• Price / Book: 1.09

Miscellaneous

• Outstanding Shares: 13,257,000
• Free Float: 11,852,000
• Market Cap: $16.57 million
• Optionable: Not Optionable
• Beta: 1.25